Assessment of malignancy in pulmonary lesions: FDG dual-head coincidence gamma camera imaging in association with serum tumor marker measurement

Journal of Nuclear Medicine

Volumn 41, Issue 11, 2000, Pages 1801-1807

  Bousson, V ^a   Moretti, J L ^a   Weinmann, P ^a   Safi, N ^a   Tamgac, F ^a   Groiselle, C ^a   De Beco, V ^a   Hillali, Y ^a   Valeyre, D ^a   Breau, J L ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Dual detector coincidence imaging; FDG; Pulmonary lesions; Serum markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; FLUORODEOXYGLUCOSE; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG TUMOR LEVEL; FEMALE; HUMAN; LUNG CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTILLATION CAMERA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033762948     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Epidemiology and etiology of lung cancer
2. The national cancer data base report on lung cancer
3. Glucose utilization in vivo by human pulmonary neoplasm
4. Prospective investigation of positron emission tomography in lung nodules
5. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET
6. 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer
7. 18FDG positron emission tomography in the staging of non-small cell lung cancer
8. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
9. Positron emission tomography: A financial and operational analysis
10. Performance characteristics of a 511-KeV collimator for imaging positron emission with a standard gamma camera
11. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxyglucose (FDG): Initial evaluation in oncology and comparison with FDG PET
12. Technology for FDG-SPECT with a relatively inexpensive gamma-camera (work in progress)
13. Coincidence imaging with a dual-head scintillation camera
14. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner
15. A clinical perspective of accelerated statistical reconstruction
16. The changing design of positron imaging systems
17. Untreated lung cancer: Quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans
18. Specific carcinoembryonic antigens of the human digestive system
19. Cytokeratins in different type of human lung cancer as monitored by chain-specific monoclonal antibodies
20. Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer
21. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer
22. Assessment of serum CYFRA 21-1 in lung cancer
23. Tumor markers in the diagnosis of bronchial carcinoma: New options using fuzzy logic-based tumor marker profiles
24. Detection of malignancies with SPECT versus PET with 2-[fluorine-18]fluoro-2-deoxy-D-glucose
25. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
26. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders
27. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: Comparison with FDG PET
28. 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras
29. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
30. Pulmonary abnormalities and PET data analysis: A retrospective study
31. Fluorine-18-fluorodeoxyglucose uptake in pneumonia
32. F-18 FDG dual head gamma camera coincidence imaging in evaluation of tumor/background ratio in pulmonary lesions
33. Bronchioloalveolar carcinoma: Focal area of ground-glass attenuation at thin-section CT as an early sign
34. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar carcinoma
35. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images
36. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent mutiphasic health testing and services
37. Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions
38. Effect of age and cigarette smoking on carcinoembryonic antigen levels
39. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: A decision analysis